Preclinical biotech developing next-generation pneumococcal vaccines.
Industry: Health Care
First Day Return: +63.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/22/2020 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 15.6 |
Deal Size ($mm) | $250 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/11/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $250 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Foster City, CA, United States |
Founded | 2013 |
Employees at IPO | 43 |
Website www.vaxcyte.com |